Yervoy (ipilimumab) - BMS
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Bavencio (avelumab) - EMD Serono
Keytruda (pembrolizumab) - Merck (MSD)
sunitinib - Generic mfg.
INSPIRE-RCC: First-Line Systemic Therapies in Advanced Renal Cell Carcinoma in Spain (clinicaltrials.gov) - Oct 2, 2026 - P=N/A | N=1200 | Active, not recruiting | Sponsor: Bristol-Myers Squibb 
New trial • Genito-urinary Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT07852884
 
Oct 2, 2026
 
Prev Next